Uncomplicated Urinary Tract Infections: From an Invisible Impact to a Visible Change in Complex Care
Uncomplicated urinary tract infections can cause significant physical and emotional burden for patients, with high rates of recurrence. The challenges of treating uncomplicated urinary tract infections are exacerbated by rising antimicrobial resistance in key uropathogens, primarily Escherichia coli, on a global scale. Clinicians should consider drug, pathogen, and host-related factors when selecting the most appropriate therapy.
Authors
- Jazmín Díaz-Regañón (ORCID: https://orcid.org/0000-0003-1393-6951)
- Vanessa Faria Cortes (ORCID: https://orcid.org/0000-0002-6464-7634)
- Ai-nee Lim
- Rafael Cantón
Institutions
- Instituto de Salud Carlos III (ES)
- GlaxoSmithKline (Croatia) (HR)
- Centro de Investigación Biomédica en Red (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Whittington Health NHS Trust (GB)
- GlaxoSmithKline (Spain) (ES)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2026-02-11
- DOI
- https://doi.org/10.1093/cid/ciaf705
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00